A Mouse Homolog of a Human TP53 Germline Mutation Reveals a Lipolytic Activity of p53 - ScienceDirect
The hot-spot p53R172H mutant promotes formation of giant spermatogonia triggered by DNA damage | Oncogene
The generation of a mouse containing a p53R172H substitution. ( a ) The... | Download Scientific Diagram
Figures and data in BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function | eLife
p53 transcripts in p53 +/+ and p53 R172H/R172H mice testes. (a) p53... | Download Scientific Diagram
Insights into Wild‐Type and Mutant p53 Functions Provided by Genetically Engineered Mice - Donehower - 2014 - Human Mutation - Wiley Online Library
Mutant p53 suppresses innate immune signaling to promote tumorigenesis | bioRxiv
GOF p53 interacts with Med17 and amino acid acids at mouse p53 L25, W26... | Download Scientific Diagram
Mutant p53 R172H gain of function. A. Representative pictures of... | Download Scientific Diagram
The p53R172H Mutant Does Not Enhance Hepatocellular Carcinoma Development and Progression | PLOS ONE
Addgene: Lox-stop-Lox p53 R172H
High metastatic potential in mice inheriting a targeted p53 missense mutation | PNAS
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome: Cell
Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice. - Abstract - Europe PMC
The hot-spot p53R172H mutant promotes formation of giant spermatogonia triggered by DNA damage | Oncogene
p53_mouse
The hot-spot p53R172H mutant promotes formation of giant spermatogonia triggered by DNA damage | Oncogene
The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3 | Nature Communications
The TP53 Website - Mutant TP53 an Oncogene!
Frontiers | Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer
Addgene: Lox-stop-Lox p53 R172H
Biomolecules | Free Full-Text | Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome: Cell
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses | The EMBO Journal
